<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">33348493</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1878-8769</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>145</Volume>
            <PubDate>
              <Year>2021</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>World neurosurgery</Title>
          <ISOAbbreviation>World Neurosurg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In Reply to the Letter to the Editor Regarding "Decompressive Craniectomy for Patients with Traumatic Brain Injury: A Pooled Analysis of Randomized Controlled Trials".</ArticleTitle>
        <Pagination>
          <MedlinePgn>512</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1878-8750(20)32273-7</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2020.10.081</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Guangyu</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Medicine, Medical College of Yangzhou University, Yangzhou University, Yangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Neuro-intensive Care Unit, Clinical Medical College of Yangzhou University, Yangzhou University, Yangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yuping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Neuro-intensive Care Unit, Clinical Medical College of Yangzhou University, Yangzhou University, Yangzhou, China. Electronic address: liyuping2011@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>World Neurosurg</MedlineTA>
        <NlmUniqueID>101528275</NlmUniqueID>
        <ISSNLinking>1878-8750</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33348493</ArticleId>
        <ArticleId IdType="pii">S1878-8750(20)32273-7</ArticleId>
        <ArticleId IdType="doi">10.1016/j.wneu.2020.10.081</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  
  
  
  
 <!-- AbstractText, Identifier for author, ArticleDate, CitationSubset -->
  
  
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">33348557</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1424-8220</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Dec</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Sensors (Basel, Switzerland)</Title>
          <ISOAbbreviation>Sensors (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>E</i><sup>2</sup><i>JSL</i>: Energy Efficient Joint Time Synchronization and Localization Algorithm Using Ray Tracing Model.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">E7222</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/s20247222</ELocationID>
        <Abstract>
          <AbstractText>In underwater wireless sensor networks (UWSNs), localization and time synchronization are vital services that have been tackled independently. By combining localization and time synchronization, could save nodes energy and improve accuracy jointly. Therefore, it is of great significance to study joint synchronization and localization of underwater sensors with low energy consumption. In this paper, we propose the energy-efficient joint framework of localization and time synchronization, in which the stratification effect is considered by using a ray-tracing approach. Based on Snell's law, ray tracing is applied to compensate for the variation of sound speed, this is one of the contributions of this article. Another contribution of this article is the iteration process which is used to improve the accuracy of localization and time synchronization. Simulation results show that the proposed joint approach outperforms the existing approaches in both energy efficiency and accuracy. This study also calculates Cramer-Rao lower bound to prove the convergence of the proposed technique along with the calculation of complexity of the proposed algorithm to show that the provided study takes less running time compared to the existing techniques.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shams</LastName>
            <ForeName>Rehan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Telecommunication, Sir Syed University of Engineering and Technology, Karachi 75300, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Otero</LastName>
            <ForeName>Pablo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3042-4392</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Telecommunication, Universidad De Malaga, E-29071 Málaga, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aamir</LastName>
            <ForeName>Muhammad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-6969-6101</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Telecommunication, Sir Syed University of Engineering and Technology, Karachi 75300, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanif</LastName>
            <ForeName>Fozia</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Mathematics, University of Karachi, Karachi 75300, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Sensors (Basel)</MedlineTA>
        <NlmUniqueID>101204366</NlmUniqueID>
        <ISSNLinking>1424-8220</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">energy efficiency</Keyword>
        <Keyword MajorTopicYN="N">localization</Keyword>
        <Keyword MajorTopicYN="N">ray tracing</Keyword>
        <Keyword MajorTopicYN="N">stratification effect</Keyword>
        <Keyword MajorTopicYN="N">time synchronization</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>09</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33348557</ArticleId>
        <ArticleId IdType="pii">s20247222</ArticleId>
        <ArticleId IdType="doi">10.3390/s20247222</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  
  
  
  
  
  
  
  
  
  
<!-- commentcorrections -->
  
  
 <PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">23096130</PMID>
    <DateCompleted>
      <Year>2013</Year>
      <Month>05</Month>
      <Day>02</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>08</Day>
    </DateRevised>
    <Article PubModel="Print-Electronic">
      <Journal>
        <ISSN IssnType="Electronic">1096-9896</ISSN>
        <JournalIssue CitedMedium="Internet">
          <Volume>229</Volume>
          <Issue>5</Issue>
          <PubDate>
            <Year>2013</Year>
            <Month>Apr</Month>
          </PubDate>
        </JournalIssue>
        <Title>The Journal of pathology</Title>
        <ISOAbbreviation>J Pathol</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Whole-genome methylation analysis of benign and malignant colorectal tumours.</ArticleTitle>
      <Pagination>
        <MedlinePgn>697-704</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1002/path.4132</ELocationID>
      <Abstract>
        <AbstractText>Changes in DNA methylation, whether hypo- or hypermethylation, have been shown to be associated with the progression of colorectal cancer. Methylation changes substantially in the progression from normal mucosa to adenoma and to carcinoma. This phenomenon has not been studied extensively and studies have been restricted to individual CpG islands, rather than taking a whole-genome approach. We aimed to study genome-wide methylation changes in colorectal cancer. We obtained 10 fresh-frozen normal tissue-cancer sample pairs, and five fresh-frozen adenoma samples. These were run on the lllumina HumanMethylation27 whole-genome methylation analysis system. Differential methylation between normal tissue, adenoma and carcinoma was analysed using Bayesian regression modelling, gene set enrichment analysis (GSEA) and hierarchical clustering (HC). The highest-rated individual gene for differential methylation in carcinomas versus normal tissue and adenomas versus normal tissue was GRASP (padjusted  = 1.59 × 10(-5) , BF = 12.62, padjusted  = 1.68 × 10(-6) , BF = 14.53). The highest-rated gene when comparing carcinomas versus adenomas was ATM (padjusted  = 2.0 × 10(-4) , BF = 10.17). Hierarchical clustering demonstrated poor clustering by the CIMP criteria for methylation. GSEA demonstrated methylation changes in the Netrin-DCC and SLIT-ROBO pathways. Widespread changes in DNA methylation are seen in the transition from adenoma to carcinoma. The finding that GRASP, which encodes the general receptor for phosphoinositide 1-associated scaffold protein, was differentially methylated in colorectal cancer is interesting. This may be a potential biomarker for colorectal cancer.</AbstractText>
        <CopyrightInformation>Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Beggs</LastName>
          <ForeName>Andrew D</ForeName>
          <Initials>AD</Initials>
          <AffiliationInfo>
            <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, UK. abeggs@well.ox.ac.uk</Affiliation>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Jones</LastName>
          <ForeName>Angela</ForeName>
          <Initials>A</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>El-Bahrawy</LastName>
          <ForeName>Mona</ForeName>
          <Initials>M</Initials>
        </Author>
        <Author ValidYN="N">
          <LastName>El-Bahwary</LastName>
          <ForeName>Mona</ForeName>
          <Initials>M</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Abulafi</LastName>
          <ForeName>Muti</ForeName>
          <Initials>M</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Hodgson</LastName>
          <ForeName>Shirley V</ForeName>
          <Initials>SV</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Tomlinson</LastName>
          <ForeName>Ian P M</ForeName>
          <Initials>IP</Initials>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <GrantList CompleteYN="Y">
        <Grant>
          <GrantID>090532</GrantID>
          <Agency>Wellcome Trust</Agency>
          <Country>United Kingdom</Country>
        </Grant>
        <Grant>
          <GrantID>090532/Z/09/Z</GrantID>
          <Agency>Wellcome Trust</Agency>
          <Country>United Kingdom</Country>
        </Grant>
      </GrantList>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
        <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
      </PublicationTypeList>
      <ArticleDate DateType="Electronic">
        <Year>2013</Year>
        <Month>01</Month>
        <Day>24</Day>
      </ArticleDate>
    </Article>
    <MedlineJournalInfo>
      <Country>England</Country>
      <MedlineTA>J Pathol</MedlineTA>
      <NlmUniqueID>0204634</NlmUniqueID>
      <ISSNLinking>0022-3417</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="C117307">KRAS protein, human</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="C410230">tamalin protein, human</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>EC 2.7.11.1</RegistryNumber>
        <NameOfSubstance UI="C482119">BRAF protein, human</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>EC 2.7.11.1</RegistryNumber>
        <NameOfSubstance UI="D048493">Proto-Oncogene Proteins B-raf</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>EC 3.6.5.2</RegistryNumber>
        <NameOfSubstance UI="D016283">Proto-Oncogene Proteins p21(ras)</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>EC 3.6.5.2</RegistryNumber>
        <NameOfSubstance UI="D018631">ras Proteins</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <CommentsCorrectionsList>
      <CommentsCorrections RefType="ErratumIn">
        <RefSource>J Pathol. 2013 Dec;231(4):543</RefSource>
        <Note>El-Bahwary, Mona [corrected to El-Bahrawy, Mona]</Note>
      </CommentsCorrections>
    </CommentsCorrectionsList>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D053842" MajorTopicYN="N">Microsatellite Instability</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D048493" MajorTopicYN="N">Proto-Oncogene Proteins B-raf</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D016283" MajorTopicYN="N">Proto-Oncogene Proteins p21(ras)</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D018631" MajorTopicYN="N">ras Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
      </MeshHeading>
    </MeshHeadingList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="received">
        <Year>2012</Year>
        <Month>07</Month>
        <Day>12</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="revised">
        <Year>2012</Year>
        <Month>10</Month>
        <Day>02</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="accepted">
        <Year>2012</Year>
        <Month>10</Month>
        <Day>10</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>2012</Year>
        <Month>10</Month>
        <Day>26</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2012</Year>
        <Month>10</Month>
        <Day>26</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2013</Year>
        <Month>5</Month>
        <Day>3</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">23096130</ArticleId>
      <ArticleId IdType="doi">10.1002/path.4132</ArticleId>
      <ArticleId IdType="pmc">PMC3619233</ArticleId>
    </ArticleIdList>
    <ReferenceList>
      <Reference>
        <Citation>Science. 2001 Mar 9;291(5510):1928-38</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">11239147</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16199517</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Biochem Biophys Res Commun. 2006 Jun 9;344(3):821-6</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16631604</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Genome Res. 2012 Feb;22(2):271-82</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">21659424</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Cell. 1998 Mar 20;92(6):713-23</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9529248</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9342-7</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">12867595</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Cancer Res. 2008 Oct 15;68(20):8541-6</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18922929</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>BMC Cancer. 2007;7:72</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17474983</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">10411935</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Virchows Arch. 2009 Dec;455(6):485-94</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">19911194</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Pathol. 2011 Jan;223(2):162-76</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">21125673</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4176-84</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">15217955</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Epigenetics. 2011 Nov 01;3:6</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">22414247</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Oncogene. 2002 May 30;21(24):3864-71</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">12032824</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Nat Genet. 2006 Jul;38(7):787-93</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16804544</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Pathol. 2011 Nov;225(3):336-43</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">21660972</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>BMC Cancer. 2010;10:227</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">20492682</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Mol Cancer. 2008;7:94</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">19117505</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Cancer Res. 2010 Jan 1;16(1):21-33</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">20028768</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Mol Biol Cell. 2010 Feb 15;21(4):562-71</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">20016009</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Gut. 2012 Jun;61(6):847-54</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">22427238</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Neuropharmacology. 2008 Sep;55(4):568-76</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18621067</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Methods Mol Biol. 2009;507:325-37</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18987824</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>PLoS One. 2008;3(11):e3698</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">19002263</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Methods Enzymol. 2006;411:134-93</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16939790</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Curr Opin Genet Dev. 2000 Feb;10(1):94-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">10679383</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Oncol Rep. 2006 Jun;15(6):1445-51</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16685378</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Gastroenterology. 2007 Dec;133(6):1849-57</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18054557</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Mol Diagn. 2006 Nov;8(5):582-8</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17065427</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Cancer Res. 2010 Mar 15;16(6):1845-55</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">20197478</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Neoplasia. 2008 Dec;10(12):1411-20</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">19048120</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Nature. 2012 Jul 19;487(7407):330-7</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">22810696</ArticleId>
        </ArticleIdList>
      </Reference>
    </ReferenceList>
  </PubmedData>
</PubmedArticle>
  
  
  
  
  
  
  
<!-- OtherAbstract: Abstract contains attribute that must be cancelleted -->
  
  
  
  
   <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">33349061</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">1012-5302</ISSN>
          <JournalIssue CitedMedium="Print">
            <PubDate>
              <Year>2020</Year>
              <Month>Dec</Month>
              <Day>22</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pflege</Title>
          <ISOAbbreviation>Pflege</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Die Problematik der Implementierung von Kinästhetik in Einrichtungen der stationären Langzeitpflege - Eine Multiple Case-Study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-9</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1024/1012-5302/a000780</ELocationID>
        <Abstract>
          <AbstractText>Difficulty of implementing kinaesthetics in long-term care institutions - A multiple case-study <b>Abstract.</b> <i>Background:</i> Resources have been invested from long-term care institutions for the development of nursing staffs' kinaesthetics competence for years. Recent studies have shown that implementing or sustainably promoting the kinaesthetics competence is problematic, but in-depth knowledge of the causes thereof is lacking. <i>Aim:</i> Which barriers impede a sustainable implementation of kinaesthetics in long-term care institutions? <i>Method:</i> A "multiple case-study" was carried out in three institutions located in the German-speaking part of Switzerland. The data from guide-based interviews and (case-related) literature on the external context was inductively condensed in the within-case analysis. The results were then compared in the cross-case synthesis and summarized in an abstract way. <i>Results:</i> The synthesis showed that the implementation of kinaesthetics can be influenced negatively at three different institutional levels - management, nursing team and individual nursing staff - as well as by external factors. <i>Conclusions:</i> In nursing practice and nursing science, as well as in the health care sector, a basic understanding of kinaesthetics in the context of professional nursing care is required. Especially those responsible for management and implementation must be aware of possible barriers in order to develop appropriate strategies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maurer</LastName>
            <ForeName>Carola</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-2731-7767</Identifier>
            <AffiliationInfo>
              <Affiliation>Institut für Pflegewissenschaft, Universität Wien.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institut für Angewandte Pflegewissenschaft IPW-OST, OST - Ostschweizer Fachhochschule, St. Gallen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gattinger</LastName>
            <ForeName>Heidrun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Angewandte Pflegewissenschaft IPW-OST, OST - Ostschweizer Fachhochschule, St. Gallen.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mayer</LastName>
            <ForeName>Hanna</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institut für Pflegewissenschaft, Universität Wien.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Pflege</MedlineTA>
        <NlmUniqueID>8907069</NlmUniqueID>
        <ISSNLinking>1012-5302</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText><b>Zusammenfassung.</b> <i>Hintergrund:</i> Einrichtungen der stationären Langzeitpflege investieren seit Jahren Ressourcen in die Entwicklung der Kinästhetikkompetenz der Pflegenden. Aus aktuellen Studien geht hervor, dass die Implementierung, bzw. die nachhaltige Förderung der Kinästhetikkompetenz problematisch ist, vertiefte Erkenntnisse zu den Ursachen fehlen jedoch. <i>Fragestellung:</i> Welche Hemmnisse verhindern eine nachhaltige Implementierung von Kinästhetik in Einrichtungen der stationären Langzeitpflege? <i>Methode:</i> Es wurde eine Multiple Case-Study in drei Einrichtungen der deutschsprachigen Schweiz durchgeführt. Aus leitfadengestützten Interviews und (fallbezogener) Literatur zum externen Kontext wurden in den Within-Case-Analysen die Daten induktiv verdichtet und diese Ergebnisse in der Cross-Case-Synthese miteinander verglichen und abstrahierend zusammengeführt. <i>Ergebnisse:</i> Die Synthese zeigt, dass die Implementierung von Kinästhetik innerhalb der Einrichtung auf drei verschiedenen Ebenen – der Leitungs-, Pflegeteam- und Pflegeperson-Ebene – als auch durch externe Faktoren negativ beeinflusst werden kann. <i>Schlussfolgerungen:</i> In der Pflegepraxis und -wissenschaft sowie im Gesundheitswesen benötigt es ein grundlegendes Verständnis von Kinästhetik und wie dieses im Kontext des professionellen Pflegehandelns einzuordnen ist. Insbesondere Leitungs- und implementierungsverantwortliche Personen müssen mögliche Hemmnisse kennen, um entsprechende Strategien entwickeln zu können.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Implementation</Keyword>
        <Keyword MajorTopicYN="N">Implementierung</Keyword>
        <Keyword MajorTopicYN="N">Kinästhetik</Keyword>
        <Keyword MajorTopicYN="N">Kompetenzentwicklung</Keyword>
        <Keyword MajorTopicYN="N">Langzeitpflege</Keyword>
        <Keyword MajorTopicYN="N">Multiple Case-Study</Keyword>
        <Keyword MajorTopicYN="N">development of competences</Keyword>
        <Keyword MajorTopicYN="N">kinaesthetics</Keyword>
        <Keyword MajorTopicYN="N">long-term care</Keyword>
        <Keyword MajorTopicYN="N">multiple case-study</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>31</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349061</ArticleId>
        <ArticleId IdType="doi">10.1024/1012-5302/a000780</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  
  
  
<!-- Coistatement, DataBankList -->
  
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">33349332</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2050-084X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Dec</Month>
              <Day>22</Day>
            </PubDate>
          </JournalIssue>
          <Title>eLife</Title>
          <ISOAbbreviation>Elife</ISOAbbreviation>
        </Journal>
        <ArticleTitle>MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.52212</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">e52212</ELocationID>
        <Abstract>
          <AbstractText>Given its glycemic efficacy and ability to reduce the body weight, glucagon-like peptide 1 receptor (GLP-1R) agonism has emerged as a preferred treatment for diabetes associated with obesity. We here report that a small-molecule Class 1 histone deacetylase (HDAC) inhibitor Entinostat (MS-275) enhances GLP-1R agonism to potentiate glucose-stimulated insulin secretion and decrease body weight in diet-induced obese (DIO) mice. MS-275 is not an agonist or allosteric activator of GLP-1R but enhances the sustained receptor-mediated signaling through the modulation of the expression of proteins involved in the signaling pathway. MS-275 and liraglutide combined therapy improved fasting glycemia upon short-term treatment and a chronic administration causes a reduction of obesity in DIO mice. Overall, our results emphasize the therapeutic potential of MS-275 as an adjunct to GLP-1R therapy in the treatment of diabetes and obesity.</AbstractText>
          <CopyrightInformation>© 2020, Bele et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bele</LastName>
            <ForeName>Shilpak</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Dr. Reddy's Institute of Life Sciences University of Hyderabad Campus, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Manipal Academy of Higher Education, Manipal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Girada</LastName>
            <ForeName>Shravan Babu</ForeName>
            <Initials>SB</Initials>
            <AffiliationInfo>
              <Affiliation>Dr. Reddy's Institute of Life Sciences University of Hyderabad Campus, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ray</LastName>
            <ForeName>Aramita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Dr. Reddy's Institute of Life Sciences University of Hyderabad Campus, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Abhishek</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Diabetes Institute, Ohio University, Athens, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oruganti</LastName>
            <ForeName>Srinivas</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Dr. Reddy's Institute of Life Sciences University of Hyderabad Campus, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prakash Babu</LastName>
            <ForeName>Phanithi</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences, University of Hyderabad, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rayalla</LastName>
            <ForeName>Rahul Sr</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences, University of Hyderabad, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kalivendi</LastName>
            <ForeName>Shashi Vardhan</ForeName>
            <Initials>SV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Applied Biology, Indian Institute of Chemical Technology, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ibrahim</LastName>
            <ForeName>Ahamed</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Lipid Chemistry, National Institute of Nutrition Hyderabad, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puri</LastName>
            <ForeName>Vishwajeet</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Diabetes Institute, Ohio University, Athens, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adalla</LastName>
            <ForeName>Venkateswar</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Katika</LastName>
            <ForeName>Madhumohan R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Stem Cell and Regenerative Medicine Department, Nizam's Institute of Medical Sciences, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DiMarchi</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Indiana University, Bloomington, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mitra</LastName>
            <ForeName>Prasenjit</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6494-4623</Identifier>
            <AffiliationInfo>
              <Affiliation>Dr. Reddy's Institute of Life Sciences University of Hyderabad Campus, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>GEO</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>GSE139147</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>EMR/2016/007057</GrantID>
            <Agency>Department of Science and Technology, Ministry of Science and Technology</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>DK101711</GrantID>
            <Agency>National Institutes of Health</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>Fellowship support</GrantID>
            <Agency>Indian Council of Medical Research</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Elife</MedlineTA>
        <NlmUniqueID>101579614</NlmUniqueID>
        <ISSNLinking>2050-084X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HDAC inhibition</Keyword>
        <Keyword MajorTopicYN="N">cell biology</Keyword>
        <Keyword MajorTopicYN="N">energy expenditure</Keyword>
        <Keyword MajorTopicYN="N">glucagon-like peptide-1 receptor</Keyword>
        <Keyword MajorTopicYN="N">glycemic control</Keyword>
        <Keyword MajorTopicYN="N">insulin secretion</Keyword>
        <Keyword MajorTopicYN="N">medicine</Keyword>
        <Keyword MajorTopicYN="N">mouse</Keyword>
        <Keyword MajorTopicYN="N">obesity</Keyword>
      </KeywordList>
      <CoiStatement>SB, SG, AR, AG, SO, PP, RR, SK, AI, VP, VA, MK, RD, PM No competing interests declared</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>35</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349332</ArticleId>
        <ArticleId IdType="doi">10.7554/eLife.52212</ArticleId>
        <ArticleId IdType="pii">52212</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  
  
  
  
  
  
  
  
  
  
  
  
  
<!--  Investigators, CollectiveName for authors -->
  
  
  
   <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">33349374</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1097-6760</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>77</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of emergency medicine</Title>
          <ISOAbbreviation>Ann Emerg Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1-e57</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S0196-0644(20)31355-X</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.annemergmed.2020.10.024</ELocationID>
        <Abstract>
          <AbstractText>This clinical policy from the American College of Emergency Physicians is a revision of the 2009 "Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia." A writing subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer the following clinical questions: (1) In the adult emergency department patient diagnosed with community-acquired pneumonia, what clinical decision aids can inform the determination of patient disposition? (2) In the adult emergency department patient with community-acquired pneumonia, what biomarkers can be used to direct initial antimicrobial therapy? (3) In the adult emergency department patient diagnosed with community-acquired pneumonia, does a single dose of parenteral antibiotics in the emergency department followed by oral treatment versus oral treatment alone improve outcomes? Evidence was graded and recommendations were made based on the strength of the available data.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <CollectiveName>American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Community-Acquired Pneumonia</CollectiveName>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Michael D</ForeName>
            <Initials>MD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fee</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mace</LastName>
            <ForeName>Sharon E</ForeName>
            <Initials>SE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maughan</LastName>
            <ForeName>Brandon</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perkins</LastName>
            <ForeName>John C</ForeName>
            <Initials>JC</Initials>
            <Suffix>Jr</Suffix>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaji</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wolf</LastName>
            <ForeName>Stephen J</ForeName>
            <Initials>SJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ann Emerg Med</MedlineTA>
        <NlmUniqueID>8002646</NlmUniqueID>
        <ISSNLinking>0196-0644</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Wolf</LastName>
          <ForeName>Stephen J</ForeName>
          <Initials>SJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Byyny</LastName>
          <ForeName>Richard</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Carpenter</LastName>
          <ForeName>Christopher R</ForeName>
          <Initials>CR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Diercks</LastName>
          <ForeName>Deborah B</ForeName>
          <Initials>DB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gemme</LastName>
          <ForeName>Seth R</ForeName>
          <Initials>SR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gerardo</LastName>
          <ForeName>Charles J</ForeName>
          <Initials>CJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Godwin</LastName>
          <ForeName>Steven A</ForeName>
          <Initials>SA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hahn</LastName>
          <ForeName>Sigrid A</ForeName>
          <Initials>SA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hatten</LastName>
          <ForeName>Benjamin W</ForeName>
          <Initials>BW</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Haukoos</LastName>
          <ForeName>Jason S</ForeName>
          <Initials>JS</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hickey</LastName>
          <ForeName>Sean M</ForeName>
          <Initials>SM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kaji</LastName>
          <ForeName>Amy</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kwok</LastName>
          <ForeName>Heemun</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lo</LastName>
          <ForeName>Bruce M</ForeName>
          <Initials>BM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mace</LastName>
          <ForeName>Sharon E</ForeName>
          <Initials>SE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Nazarian</LastName>
          <ForeName>Devorah J</ForeName>
          <Initials>DJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Promes</LastName>
          <ForeName>Susan B</ForeName>
          <Initials>SB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Shah</LastName>
          <ForeName>Kaushal H</ForeName>
          <Initials>KH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Shih</LastName>
          <ForeName>Richard D</ForeName>
          <Initials>RD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Silvers</LastName>
          <ForeName>Scott M</ForeName>
          <Initials>SM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Smith</LastName>
          <ForeName>Michael D</ForeName>
          <Initials>MD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Thiessen</LastName>
          <ForeName>Molly E W</ForeName>
          <Initials>MEW</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tomaszewski</LastName>
          <ForeName>Christian A</ForeName>
          <Initials>CA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Valente</LastName>
          <ForeName>Jonathan H</ForeName>
          <Initials>JH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Wall</LastName>
          <ForeName>Stephen P</ForeName>
          <Initials>SP</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Winger</LastName>
          <ForeName>Justin</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cantrill</LastName>
          <ForeName>Stephen V</ForeName>
          <Initials>SV</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hirshon</LastName>
          <ForeName>Jon M</ForeName>
          <Initials>JM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mims</LastName>
          <ForeName>Mandie</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schulz</LastName>
          <ForeName>Travis</ForeName>
          <Initials>T</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349374</ArticleId>
        <ArticleId IdType="pii">S0196-0644(20)31355-X</ArticleId>
        <ArticleId IdType="doi">10.1016/j.annemergmed.2020.10.024</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  
  
  
  
  
  
  
  
  
  
  
  
<!--  ReferenceList  -->
  
 <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">33349232</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2369</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Dec</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC nephrology</Title>
          <ISOAbbreviation>BMC Nephrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Correction to: The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>545</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-020-02199-5</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Weldegiorgis</LastName>
            <ForeName>Misghina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. m.weldegiorgis@imperial.ac.uk.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia. m.weldegiorgis@imperial.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woodward</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>BMC Nephrol</MedlineTA>
        <NlmUniqueID>100967793</NlmUniqueID>
        <ISSNLinking>1471-2369</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>BMC Nephrol. 2020 Nov 25;21(1):506</RefSource>
          <PMID Version="1">33238919</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349232</ArticleId>
        <ArticleId IdType="doi">10.1186/s12882-020-02199-5</ArticleId>
        <ArticleId IdType="pii">10.1186/s12882-020-02199-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Reference</Title>
        <Reference>
          <Citation>Weldegiorgis M, Woodward M. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020;21:506 https://doi.org/10.1186/s12882-020-02151-7 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12882-020-02151-7</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  
  
  
  
  
  
  
  
  
  
 
  
<!--  VernacularTitle -->
  
  
   <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">33349423</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1166-7087</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>30</Volume>
            <Issue>12S</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie</Title>
          <ISOAbbreviation>Prog Urol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Update 2020-2022 of French ccAFU guidelines - Editorial].</ArticleTitle>
        <Pagination>
          <MedlinePgn>S1</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1166-7087(20)30748-X</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1166-7087(20)30748-X</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Méjean</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Hôpital européen Georges-Pompidou (HEGP), 20, rue Leblanc, 75015, Paris, France. Electronic address: arnaud.mejean@aphp.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>fre</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Actualisation 2020–2022 des recommandations françaises du Comité de cancérologie de l’AFU – Éditorial.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Prog Urol</MedlineTA>
        <NlmUniqueID>9307844</NlmUniqueID>
        <ISSNLinking>1166-7087</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349423</ArticleId>
        <ArticleId IdType="pii">S1166-7087(20)30748-X</ArticleId>
        <ArticleId IdType="doi">10.1016/S1166-7087(20)30748-X</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">33349424</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1166-7087</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>30</Volume>
            <Issue>12S</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie</Title>
          <ISOAbbreviation>Prog Urol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[French ccAFU guidelines - update 2020-2022: prostate cancer].</ArticleTitle>
        <Pagination>
          <MedlinePgn>S136-S251</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S1166-7087(20)30752-1</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1166-7087(20)30752-1</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">- The purpose of the guidelines national committee ccAFU was to propose updated french guidelines for prostate cancer.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">- A Medline search was achieved between 2018 and 2020, as regards diagnosis, options of treatment and follow-up of prostate cancer (PCA), and to evaluate the different references specifying their levels of evidence.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">- The guidelines outline the genetics, epidemiology and diagnosis of prostate cancer, as well as the concepts of screening and early detection. MRI, the gold standard imaging test for localized cancer, is indicated before prostate biopsies are performed. The therapeutic methods are detailed and indicated according to the clinical situation. Active surveillance is a reference therapeutic option for low-risk tumours with a low evolutionary risk. Early salvage radiotherapy is indicated in case of biological recurrence after radical prostatectomy. Androgen deprivation therapy (ADT) remains the backbone therapy in the metastatic stage. Docetaxel in combination with ADT improves overall first-line survival in synchronous metastatic prostate cancer. In this situation, the combination of ADT with abiraterone is also a standard of care regardless of tumor volume. Recent data indicate that ADT should be indicated with a new generation of hormone therapy (Apalutamide or Enzalutamide) in metastatic synchronous or metachronous patients, regardless of tumour volume. Local treatment of prostate cancer with radiotherapy improves survival in synchronous oligometastatic patients. Targeted treatment of metastases is being evaluated. In patients with castration-resistant prostate cancer (CRPC), new therapies that have emerged in recent years help to better control tumor progression and improve survival.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">- These updated french guidelines will contribute to increase the level of urological care for the diagnosis and treatment for prostate cancer.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rozet</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France; Institut mutualiste Montsouris, 42 boulevard Jourdan, 75014 Paris, France. Electronic address: francois.rozet@imm.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mongiat-Artus</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hennequin</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beauval</LastName>
            <ForeName>J B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beuzeboc</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cormier</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fromont-Hankard</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mathieu</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ploussard</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Renard-Penna</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brenot-Rossi</LastName>
            <ForeName>I</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bruyere</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cochet</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crehange</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cussenot</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lebret</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rebillard</LastName>
            <ForeName>X</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Soulié</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brureau</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Méjean</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11 rue Viète 75017 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>fre</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D017065">Practice Guideline</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : cancer de la prostate.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Prog Urol</MedlineTA>
        <NlmUniqueID>9307844</NlmUniqueID>
        <ISSNLinking>1166-7087</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer de la prostate</Keyword>
        <Keyword MajorTopicYN="N">Diagnosis</Keyword>
        <Keyword MajorTopicYN="N">Diagnostic</Keyword>
        <Keyword MajorTopicYN="N">Guidelines</Keyword>
        <Keyword MajorTopicYN="N">Medical Subject Headings (MeSH)</Keyword>
        <Keyword MajorTopicYN="N">Medical Subject Headings (MeSH) Prostate cancer</Keyword>
        <Keyword MajorTopicYN="N">Recommandations</Keyword>
        <Keyword MajorTopicYN="N">Traitement</Keyword>
        <Keyword MajorTopicYN="N">Treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349424</ArticleId>
        <ArticleId IdType="pii">S1166-7087(20)30752-1</ArticleId>
        <ArticleId IdType="doi">10.1016/S1166-7087(20)30752-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>


<!--  Datacompleted -->
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">4949</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>07</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0001-5164</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>26</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta anaesthesiologica Belgica</Title>
          <ISOAbbreviation>Acta Anaesthesiol Belg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Address from the president of the Belgian Society of Anesthesia and Resuscitation].</ArticleTitle>
        <Pagination>
          <MedlinePgn>III-VI</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De Temmerman</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
          </Author>
        </AuthorList>
        <Language>fre</Language>
        <PublicationTypeList>
          <PublicationType UI="D016423">Congress</PublicationType>
          <PublicationType UI="D016456">Historical Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Allocution du president de la Société belge d'Anesthésie et de Réanimation</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Belgium</Country>
        <MedlineTA>Acta Anaesthesiol Belg</MedlineTA>
        <NlmUniqueID>0421022</NlmUniqueID>
        <ISSNLinking>0001-5164</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>Q</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001530" MajorTopicYN="N">Belgium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012151" MajorTopicYN="Y">Resuscitation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012953" MajorTopicYN="N">Societies, Dental</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">4949</ArticleId>
        <ArticleId IdType="pii">33145940</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>



<!--  Chemical List, OtherID -->

 <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">4949</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>07</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0001-5164</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>26</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta anaesthesiologica Belgica</Title>
          <ISOAbbreviation>Acta Anaesthesiol Belg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Address from the president of the Belgian Society of Anesthesia and Resuscitation].</ArticleTitle>
        <Pagination>
          <MedlinePgn>III-VI</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De Temmerman</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
          </Author>
        </AuthorList>
        <Language>fre</Language>
        <PublicationTypeList>
          <PublicationType UI="D016423">Congress</PublicationType>
          <PublicationType UI="D016456">Historical Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Allocution du president de la Société belge d'Anesthésie et de Réanimation</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Belgium</Country>
        <MedlineTA>Acta Anaesthesiol Belg</MedlineTA>
        <NlmUniqueID>0421022</NlmUniqueID>
        <ISSNLinking>0001-5164</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>Q</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001530" MajorTopicYN="N">Belgium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012151" MajorTopicYN="Y">Resuscitation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012953" MajorTopicYN="N">Societies, Dental</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">4949</ArticleId>
        <ArticleId IdType="pii">33145940</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">4957</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>07</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0001-6101</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>199</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1976</Year>
            </PubDate>
          </JournalIssue>
          <Title>Acta medica Scandinavica</Title>
          <ISOAbbreviation>Acta Med Scand</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension.</ArticleTitle>
        <Pagination>
          <MedlinePgn>263-7</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Sixteen men with previously untreated essential hypertension in WHO stage I have been studied as out-patients. Oxygen consumption, heart rate (HR), cardiac output (Q) (Cardiogreen) and intraarterial brachial pressure were recorded at rest in supine and sitting position and during steady state work at 300, 600 and 900 kpm/min. The subjects were treated with timolol as the sole drug for one year and the hemodynamic study was repeated. BP was reduced approximately 18% at rest and 14% during exercise, HR approximately 26% and the cardiac index 28% at rest supine and 32% at rest sitting. During exercise the reductions in Q were 25-30%. The calculated total peripheral resistance was significantly increased at rest as well as during exercise. The product of mean arterial pressure and HR was reduced about 40%. No severe side-effects were seen.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lund-Johansen</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Sweden</Country>
        <MedlineTA>Acta Med Scand</MedlineTA>
        <NlmUniqueID>0370330</NlmUniqueID>
        <ISSNLinking>0001-6101</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013830">Thiadiazoles</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>S</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002302" MajorTopicYN="N">Cardiac Output</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005082" MajorTopicYN="N">Physical Exertion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011412" MajorTopicYN="N">Propanolamines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013830" MajorTopicYN="N">Thiadiazoles</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014655" MajorTopicYN="N">Vascular Resistance</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherID Source="NASA">76181370</OtherID>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1976</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1976</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1976</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">4957</ArticleId>
        <ArticleId IdType="doi">10.1111/j.0954-6820.1976.tb06730.x</ArticleId>
        <ArticleId IdType="pii">33145944</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>






<!--  SupplMeshList MeshHeadingList GrantList -->

<PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">21803848</PMID>
    <DateCompleted>
      <Year>2011</Year>
      <Month>12</Month>
      <Day>20</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>08</Day>
    </DateRevised>
    <Article PubModel="Print-Electronic">
      <Journal>
        <ISSN IssnType="Electronic">1528-0020</ISSN>
        <JournalIssue CitedMedium="Internet">
          <Volume>118</Volume>
          <Issue>16</Issue>
          <PubDate>
            <Year>2011</Year>
            <Month>Oct</Month>
            <Day>20</Day>
          </PubDate>
        </JournalIssue>
        <Title>Blood</Title>
        <ISOAbbreviation>Blood</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Defective ribosome assembly in Shwachman-Diamond syndrome.</ArticleTitle>
      <Pagination>
        <MedlinePgn>4305-12</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1182/blood-2011-06-353938</ELocationID>
      <Abstract>
        <AbstractText>Shwachman-Diamond syndrome (SDS), a recessive leukemia predisposition disorder characterized by bone marrow failure, exocrine pancreatic insufficiency, skeletal abnormalities and poor growth, is caused by mutations in the highly conserved SBDS gene. Here, we test the hypothesis that defective ribosome biogenesis underlies the pathogenesis of SDS. We create conditional mutants in the essential SBDS ortholog of the ancient eukaryote Dictyostelium discoideum using temperature-sensitive, self-splicing inteins, showing that mutant cells fail to grow at the restrictive temperature because ribosomal subunit joining is markedly impaired. Remarkably, wild type human SBDS complements the growth and ribosome assembly defects in mutant Dictyostelium cells, but disease-associated human SBDS variants are defective. SBDS directly interacts with the GTPase elongation factor-like 1 (EFL1) on nascent 60S subunits in vivo and together they catalyze eviction of the ribosome antiassociation factor eukaryotic initiation factor 6 (eIF6), a prerequisite for the translational activation of ribosomes. Importantly, lymphoblasts from SDS patients harbor a striking defect in ribosomal subunit joining whose magnitude is inversely proportional to the level of SBDS protein. These findings in Dictyostelium and SDS patient cells provide compelling support for the hypothesis that SDS is a ribosomopathy caused by corruption of an essential cytoplasmic step in 60S subunit maturation.</AbstractText>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Wong</LastName>
          <ForeName>Chi C</ForeName>
          <Initials>CC</Initials>
          <AffiliationInfo>
            <Affiliation>Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.</Affiliation>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Traynor</LastName>
          <ForeName>David</ForeName>
          <Initials>D</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Basse</LastName>
          <ForeName>Nicolas</ForeName>
          <Initials>N</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Kay</LastName>
          <ForeName>Robert R</ForeName>
          <Initials>RR</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Warren</LastName>
          <ForeName>Alan J</ForeName>
          <Initials>AJ</Initials>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <GrantList CompleteYN="Y">
        <Grant>
          <GrantID>08-0183</GrantID>
          <Acronym>AICR_</Acronym>
          <Agency>Worldwide Cancer Research</Agency>
          <Country>United Kingdom</Country>
        </Grant>
        <Grant>
          <GrantID>MC_U105115237</GrantID>
          <Acronym>MRC_</Acronym>
          <Agency>Medical Research Council</Agency>
          <Country>United Kingdom</Country>
        </Grant>
        <Grant>
          <GrantID>MC_U105161083</GrantID>
          <Acronym>MRC_</Acronym>
          <Agency>Medical Research Council</Agency>
          <Country>United Kingdom</Country>
        </Grant>
      </GrantList>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
        <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
      </PublicationTypeList>
      <ArticleDate DateType="Electronic">
        <Year>2011</Year>
        <Month>07</Month>
        <Day>29</Day>
      </ArticleDate>
    </Article>
    <MedlineJournalInfo>
      <Country>United States</Country>
      <MedlineTA>Blood</MedlineTA>
      <NlmUniqueID>7603509</NlmUniqueID>
      <ISSNLinking>0006-4971</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D010448">Peptide Initiation Factors</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D015800">Protozoan Proteins</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="C470521">SBDS protein, human</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="C021019">eIF-6</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>EC 3.6.1.-</RegistryNumber>
        <NameOfSubstance UI="D020558">GTP Phosphohydrolases</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <SupplMeshList>
      <SupplMeshName Type="Disease" UI="C537330">Shwachman syndrome</SupplMeshName>
    </SupplMeshList>
    <CitationSubset>AIM</CitationSubset>
    <CitationSubset>IM</CitationSubset>
    <CommentsCorrectionsList>
      <CommentsCorrections RefType="CommentIn">
        <RefSource>Blood. 2011 Oct 20;118(16):4300-1</RefSource>
        <PMID Version="1">22021450</PMID>
      </CommentsCorrections>
    </CommentsCorrectionsList>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D001855" MajorTopicYN="N">Bone Marrow Diseases</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004023" MajorTopicYN="N">Dictyostelium</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010188" MajorTopicYN="N">Exocrine Pancreatic Insufficiency</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D020558" MajorTopicYN="N">GTP Phosphohydrolases</DescriptorName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008068" MajorTopicYN="N">Lipomatosis</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010448" MajorTopicYN="N">Peptide Initiation Factors</DescriptorName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D015800" MajorTopicYN="N">Protozoan Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D012270" MajorTopicYN="N">Ribosomes</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D000081003" MajorTopicYN="N">Shwachman-Diamond Syndrome</DescriptorName>
      </MeshHeading>
    </MeshHeadingList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="entrez">
        <Year>2011</Year>
        <Month>8</Month>
        <Day>2</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2011</Year>
        <Month>8</Month>
        <Day>2</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2011</Year>
        <Month>12</Month>
        <Day>21</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">21803848</ArticleId>
      <ArticleId IdType="pii">blood-2011-06-353938</ArticleId>
      <ArticleId IdType="doi">10.1182/blood-2011-06-353938</ArticleId>
    </ArticleIdList>
  </PubmedData>
</PubmedArticle>


<!--  Number of References -->
<PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">5004</PMID>
    <DateCompleted>
      <Year>1976</Year>
      <Month>07</Month>
      <Day>06</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>09</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Print">0003-4061</ISSN>
        <JournalIssue CitedMedium="Print">
          <Volume>16</Volume>
          <Issue>2</Issue>
          <PubDate>
            <MedlineDate>1975 Mar-Apr</MedlineDate>
          </PubDate>
        </JournalIssue>
        <Title>Annales de l'anesthesiologie francaise</Title>
        <ISOAbbreviation>Ann Anesthesiol Fr</ISOAbbreviation>
      </Journal>
      <ArticleTitle>[Disorders of body temperature regulation. 1. Physiopathological study].</ArticleTitle>
      <Pagination>
        <MedlinePgn>101-9</MedlinePgn>
      </Pagination>
      <Abstract>
        <AbstractText>In this work, disorders of thermo-regulation are first studied in a synthetic manner from the angle of cellular and haemodynamic disturbances. Then the particular physiopathological aspects concerning hypothermia and hyperthermia are looked at in succession. In his next work, the author will view the clinical and therapeutic study of these phenomena. Extensive bibliography.</AbstractText>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Constantin</LastName>
          <ForeName>B</ForeName>
          <Initials>B</Initials>
        </Author>
      </AuthorList>
      <Language>fre</Language>
      <PublicationTypeList>
        <PublicationType UI="D004740">English Abstract</PublicationType>
        <PublicationType UI="D016428">Journal Article</PublicationType>
        <PublicationType UI="D016454">Review</PublicationType>
      </PublicationTypeList>
      <VernacularTitle>Les dérèglements thermiques. 1 - Etude physio-pathologique</VernacularTitle>
    </Article>
    <MedlineJournalInfo>
      <Country>France</Country>
      <MedlineTA>Ann Anesthesiol Fr</MedlineTA>
      <NlmUniqueID>0372332</NlmUniqueID>
      <ISSNLinking>0003-4061</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>142M471B3J</RegistryNumber>
        <NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>YKH834O4BH</RegistryNumber>
        <NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D000136" MajorTopicYN="N">Acid-Base Equilibrium</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D000777" MajorTopicYN="N">Anesthetics</DescriptorName>
        <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D001790" MajorTopicYN="N">Blood Physiological Phenomena</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D001833" MajorTopicYN="Y">Body Temperature Regulation</DescriptorName>
        <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName>
        <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002319" MajorTopicYN="N">Cardiovascular System</DescriptorName>
        <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D003080" MajorTopicYN="N">Cold Temperature</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D003681" MajorTopicYN="N">Dehydration</DescriptorName>
        <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName>
        <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName>
        <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName>
        <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008305" MajorTopicYN="N">Malignant Hyperthermia</DescriptorName>
        <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008660" MajorTopicYN="N">Metabolism</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009420" MajorTopicYN="N">Nervous System</DescriptorName>
        <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName>
        <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
      </MeshHeading>
    </MeshHeadingList>
    <NumberOfReferences>35</NumberOfReferences>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="pubmed">
        <Year>1975</Year>
        <Month>3</Month>
        <Day>1</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>1975</Year>
        <Month>3</Month>
        <Day>1</Day>
        <Hour>0</Hour>
        <Minute>1</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>1975</Year>
        <Month>3</Month>
        <Day>1</Day>
        <Hour>0</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">5004</ArticleId>
      <ArticleId IdType="pii">33145953</ArticleId>
    </ArticleIdList>
  </PubmedData>
</PubmedArticle>




<!--  PersonalNameSubjectList -->

<PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">21927968</PMID>
    <DateCompleted>
      <Year>2011</Year>
      <Month>11</Month>
      <Day>30</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>08</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Electronic">1528-1132</ISSN>
        <JournalIssue CitedMedium="Internet">
          <Volume>469</Volume>
          <Issue>11</Issue>
          <PubDate>
            <Year>2011</Year>
            <Month>Nov</Month>
          </PubDate>
        </JournalIssue>
        <Title>Clinical orthopaedics and related research</Title>
        <ISOAbbreviation>Clin Orthop Relat Res</ISOAbbreviation>
      </Journal>
      <ArticleTitle>50 Years ago in CORR: Osteomyelitis since the advent of antibiotics; a study of infants and children Gordon M. Cottington, MD, Jay M. Riden, MD, and Albert B. Ferguson, Jr, MD CORR 1959;14:97-101.</ArticleTitle>
      <Pagination>
        <MedlinePgn>3257-8</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11999-011-2024-6</ELocationID>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Brand</LastName>
          <ForeName>Richard A</ForeName>
          <Initials>RA</Initials>
          <AffiliationInfo>
            <Affiliation>Clinical Orthopaedics and Related Research, 1600 Spruce Street, Philadelphia, PA, USA. dick.brand@clinorthop.org</Affiliation>
          </AffiliationInfo>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <PublicationTypeList>
        <PublicationType UI="D019215">Biography</PublicationType>
        <PublicationType UI="D016456">Historical Article</PublicationType>
        <PublicationType UI="D016428">Journal Article</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>United States</Country>
      <MedlineTA>Clin Orthop Relat Res</MedlineTA>
      <NlmUniqueID>0075674</NlmUniqueID>
      <ISSNLinking>0009-921X</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>AIM</CitationSubset>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
        <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010019" MajorTopicYN="N">Osteomyelitis</DescriptorName>
        <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
      </MeshHeading>
    </MeshHeadingList>
    <PersonalNameSubjectList>
      <PersonalNameSubject>
        <LastName>Cottington</LastName>
        <ForeName>Gordon M</ForeName>
        <Initials>GM</Initials>
      </PersonalNameSubject>
      <PersonalNameSubject>
        <LastName>Riden</LastName>
        <ForeName>Jay M</ForeName>
        <Initials>JM</Initials>
      </PersonalNameSubject>
      <PersonalNameSubject>
        <LastName>Ferguson</LastName>
        <ForeName>Albert B</ForeName>
        <Initials>AB</Initials>
        <Suffix>Jr</Suffix>
      </PersonalNameSubject>
    </PersonalNameSubjectList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="entrez">
        <Year>2011</Year>
        <Month>9</Month>
        <Day>20</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2011</Year>
        <Month>9</Month>
        <Day>20</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2011</Year>
        <Month>12</Month>
        <Day>13</Day>
        <Hour>0</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">21927968</ArticleId>
      <ArticleId IdType="doi">10.1007/s11999-011-2024-6</ArticleId>
      <ArticleId IdType="pmc">PMC3183213</ArticleId>
    </ArticleIdList>
    <ReferenceList>
      <Reference>
        <Citation>Am J Public Health. 1999 Dec;89(12):1883-5</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">10589325</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Ann Surg. 1912 Mar;55(3):375-87</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17862814</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Pediatr Orthop. 1991 May-Jun;11(3):358-63</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">2056085</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Orthop Relat Res. 2011 Nov;469(11):3257-8</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">21927968</ArticleId>
        </ArticleIdList>
      </Reference>
    </ReferenceList>
  </PubmedData>
</PubmedArticle>



<!--  OtherAbstract  multi tag text -->
<PubmedArticle>
  <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
    <PMID Version="1">23997785</PMID>
    <DateCompleted>
      <Year>2013</Year>
      <Month>09</Month>
      <Day>02</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>08</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Print">1712-9532</ISSN>
        <JournalIssue CitedMedium="Print">
          <Volume>23</Volume>
          <Issue>3</Issue>
          <PubDate>
            <Year>2012</Year>
            <Season>Fall</Season>
          </PubDate>
        </JournalIssue>
        <Title>The Canadian journal of infectious diseases &amp; medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale</Title>
        <ISOAbbreviation>Can J Infect Dis Med Microbiol</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.</ArticleTitle>
      <Pagination>
        <MedlinePgn>e55-9</MedlinePgn>
      </Pagination>
      <Abstract>
        <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Serogroup C meningococcal disease has been endemic in Canada since the early 1990s, with periods of hyperendemic disease documented in the past two decades. The present study characterized invasive serogroup C meningococci in Canada during the period from 2002 to 2009.</AbstractText>
        <AbstractText Label="METHODS" NlmCategory="METHODS">Serogroup C meningococci were serotyped using monoclonal antibodies. Their clonal types were identified by either multilocus enzyme electrophoresis or multilocus sequence typing.</AbstractText>
        <AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of invasive serogroup C Neisseria meningitidis isolates received at the National Microbiology Laboratory (Winnipeg, Manitoba) for characterization has dropped from a high of 173 isolates in 2001 to just 17 in 2009, possibly related to the introduction of the serogroup C meningococcal conjugate vaccine. Before 2006, 80% to 95% of all invasive serogroup C meningococci belonged to the electrophoreic type (ET)-15 clonal type, and the ET-37 (but not ET-15) type only accounted for up to 5% of all isolates. However, beginning in 2006, the percentage of the ET-15 clonal type decreased while the ET-37 (but not ET-15) type increased from 27% in 2006 to 52% in 2009. The percentage of invasive serogroup C isolates not belonging to either ET-15 or ET-37 also increased. Most ET-15 isolates expressed the antigenic formula of C:2a:P1.7,1 or C:2a:P1.5. In contrast, the ET-37 (but not ET-15) isolates mostly expressed the antigens of C:2a:P1.5,2 or C:2a:P1.2.</AbstractText>
        <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A shift in the antigenic and clonal type of invasive serogroup C meningococi was noted. This finding suggests vigilance in the surveillance of meningoccocal disease is warranted.</AbstractText>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Zhou</LastName>
          <ForeName>Jianwei</ForeName>
          <Initials>J</Initials>
          <AffiliationInfo>
            <Affiliation>Public Health Agency of Canada, Winnipeg, Manitoba;</Affiliation>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Jamieson</LastName>
          <ForeName>Frances</ForeName>
          <Initials>F</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Dolman</LastName>
          <ForeName>Sharon</ForeName>
          <Initials>S</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Hoang</LastName>
          <ForeName>Linda Mn</ForeName>
          <Initials>LM</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Rawte</LastName>
          <ForeName>Prasad</ForeName>
          <Initials>P</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Tsang</LastName>
          <ForeName>Raymond Sw</ForeName>
          <Initials>RS</Initials>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <GrantList CompleteYN="Y">
        <Grant>
          <Acronym>WT_</Acronym>
          <Agency>Wellcome Trust</Agency>
          <Country>United Kingdom</Country>
        </Grant>
      </GrantList>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>Egypt</Country>
      <MedlineTA>Can J Infect Dis Med Microbiol</MedlineTA>
      <NlmUniqueID>101226876</NlmUniqueID>
      <ISSNLinking>1712-9532</ISSNLinking>
    </MedlineJournalInfo>
    <OtherAbstract Type="Publisher" Language="fre">
      <AbstractText Label="HISTORIQUE">La maladie à méningocoque du sérogroupe C est endémique au Canada depuis le début des années 1990, des périodes de maladie hyperendémique étant attestées depuis vingt ans. La présente étude caractérise des groupes de méningocoques invasifs du sérogroupe C au Canada entre 2002 et 2009.</AbstractText>
      <AbstractText Label="MÉTHODOLOGIE">Les chercheurs ont sérotypé les méningocoques du sérogroupe C au moyen d’anticorps monoclonaux. Ils ont déterminé leur groupe clonal par électrophorèse d’enzyme multilocus ou par typage séquentiel multilocus.</AbstractText>
      <AbstractText Label="RÉSULTATS">Le nombre d’isolats de<i>Neisseria meningitidis</i>invasifs du sérogroupe C envoyés au<i>National Microbiology Laboratory</i>de Winnipeg, au Manitoba, en vue de leur caractérisation a fléchi d’un pic de 173 isolats en 2001 à seulement 17 en 2009, peut-être en raison de l’adoption du vaccin conjugué contre le méningocoque du sérogroupe C. Avant 2006, de 80 % à 95 % de tous les méningocoques invasifs du sérogroupe C appartenaient au groupe clonal du type électrophorétique ET-15, et l’ET-37 (mais pas l’ET-15) ne représentait que jusqu’à 5 % de tous les isolats. Cependant, à compter de 2006, le pourcentage de groupe clonal ET-15 a diminué, tandis que l’ET-37 (mais pas l’ET-15) est passé de 27 % en 2006 à 52 % en 2009. Le pourcentage d’isolats invasifs du sérogroupe C n’appartenant ni à l’ET-15 ni à l’ET-37 a également augmenté. La plupart des isolats d’ET-15 exprimaient la formule antigénique C:2a:P1.7,1 ou C:2a:P1.5. Par contre, les isolats d’ET-37 (mais pas d’ET-15) exprimaient surtout les antigènes C:2a:P1.5,2 ou C:2a:P1.2.</AbstractText>
      <AbstractText Label="CONCLUSION">Les chercheurs ont remarqué une transition du groupe antigénique et clonal des méningocoques invasifs du sérogroupe C. En raison de cette observation, il serait judicieux d’être vigilant en matière de surveillance de la maladie à méningocoque.</AbstractText>
    </OtherAbstract>
    <KeywordList Owner="NOTNLM">
      <Keyword MajorTopicYN="N">ET-15</Keyword>
      <Keyword MajorTopicYN="N">ET-37</Keyword>
      <Keyword MajorTopicYN="N">Meningococci</Keyword>
      <Keyword MajorTopicYN="N">Serogroup C</Keyword>
    </KeywordList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="entrez">
        <Year>2013</Year>
        <Month>9</Month>
        <Day>3</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2013</Year>
        <Month>9</Month>
        <Day>3</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2013</Year>
        <Month>9</Month>
        <Day>3</Day>
        <Hour>6</Hour>
        <Minute>1</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">23997785</ArticleId>
      <ArticleId IdType="pmc">PMC3476562</ArticleId>
      <ArticleId IdType="doi">10.1155/2012/131328</ArticleId>
    </ArticleIdList>
    <ReferenceList>
      <Reference>
        <Citation>Can J Infect Dis. 2002 Nov;13(6):391-6</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18159416</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can J Microbiol. 2004 Jun;50(6):433-43</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">15284889</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Dis Wkly Rep. 1989 Apr 29;15(17):89-96</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">2720807</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Mol Biol Evol. 2005 Mar;22(3):562-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">15537808</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can J Microbiol. 2003 Oct;49(10):633-8</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">14663497</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 1991 Nov;29(11):2489-93</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">1774254</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Infect Dis. 2006 May 1;193(9):1266-74</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16586364</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Infect Immun. 1987 Jun;55(6):1503-12</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">3106223</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>JAMA. 1995 Feb 1;273(5):390-4</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">7823384</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Mol Microbiol. 1996 Jun;20(6):1211-20</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">8809773</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2003 Sep;41(9):4411-4</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">12958279</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>APMIS. 1998 May;106(5):505-25</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9674888</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9501229</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2006 Aug;44(8):2743-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16891487</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2004 Apr;42(4):1460-5</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">15070989</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Vaccine. 2009 Mar 10;27(11):1735-40</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">19186206</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can J Microbiol. 2005 Jul;51(7):523-30</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16175200</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Infect Dis. 1998 Jun;177(6):1754-7</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9607865</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Pediatr Infect Dis J. 2009 Mar;28(3):220-4</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">19209096</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Infect Dis. 1993 Jun;167(6):1320-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">8501321</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can J Microbiol. 2008 Mar;54(3):229-34</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18388994</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can J Public Health. 1992 Mar-Apr;83(2):129-30</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">1617550</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>JAMA. 1995 Feb 1;273(5):383-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">7823383</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Expert Rev Vaccines. 2006 Aug;5(4):445-59</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16989625</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 1998 Aug 1;24(15):122-6</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9704541</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Infect Dis. 2003 Nov 1;37(9):1183-8</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">14557962</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Epidemiol Infect. 2000 Oct;125(2):285-98</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">11117951</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Dis Wkly Rep. 1989 Mar 18;15(11):59-62</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">2713946</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 2000 Nov 1;26(21):177-82</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">11107657</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>EMBO J. 1996 Jan 2;15(1):192-8</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">8598202</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 2007 Jun 1;33(10):1-15</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17691125</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 2001 Oct 15;27:2-36</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">11706686</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2000 Feb;38(2):941-2</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">10722324</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 2006 Apr 15;32(8):97-107</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16685767</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Infect Dis. 2005 Mar 1;40(5):e38-42</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">15714405</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Appl Environ Microbiol. 1986 May;51(5):873-84</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">2425735</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can J Public Health. 1992 Mar-Apr;83(2):138-40</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">1617554</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Infect Immun. 2000 Dec;68(12):6685-90</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">11083782</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2004 Jun;42(6):2718-23</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">15184458</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 2007 May 1;33(ACS-3):1-23</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17520774</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Pediatrics. 1977 Nov;60(5):673-80</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">411104</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>JAMA. 1998 Nov 18;280(19):1685-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9832000</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2010 Sep;48(9):3459-60</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">20631097</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Bull World Health Organ. 1996;74(4):407-11</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">8823963</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Can Commun Dis Rep. 1997 Aug 15;23(16):121-5</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">9439039</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Infect Dis. 2006 Dec 15;194(12):1791-2; author reply 1792-3</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17109354</ArticleId>
        </ArticleIdList>
      </Reference>
    </ReferenceList>
  </PubmedData>
</PubmedArticle>



<!--  Abstract copyRightInformation -->

<PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">10662553</PMID>
    <DateCompleted>
      <Year>2000</Year>
      <Month>04</Month>
      <Day>11</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>08</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Print">0888-7543</ISSN>
        <JournalIssue CitedMedium="Print">
          <Volume>63</Volume>
          <Issue>1</Issue>
          <PubDate>
            <Year>2000</Year>
            <Month>Jan</Month>
            <Day>01</Day>
          </PubDate>
        </JournalIssue>
        <Title>Genomics</Title>
        <ISOAbbreviation>Genomics</ISOAbbreviation>
      </Journal>
      <ArticleTitle>A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region.</ArticleTitle>
      <Pagination>
        <MedlinePgn>139-41</MedlinePgn>
      </Pagination>
      <Abstract>
        <AbstractText>Eleven unique cDNA fragments were identified from YAC B30H3, which spans 330 kb in the human major histocompatibility complex class I region. One fragment (CAT80) was mapped 80 kb telomeric to the HLA-A locus. Using this cDNA fragment as probe, Northern analysis reveals a ubiquitously expressed transcript of about 850 nt in all 16 tissues tested. Based on the cDNA fragment sequence, a full-length cDNA of 858 bp that contains an open reading frame of 378 bp was cloned. Within the putative polypeptide of 126 amino acids, two zinc-ribbon domains were identified: Cx2Cx15Cx2C at the N-terminal and Cx2Cx24Cx2C at the C-terminal. The C-terminal domain is well conserved throughout evolution, including archaea, yeast, Drosophila, nematodes, amphibians, and mammals. The conserved amino acid sequence, CxRCx6Yx3QxRSADEx2TxFxCx2C, is highly homologous to the yeast RNA polymerase A subunit 9 and transcription-associated proteins. Alignment with genomic DNA demonstrates that this gene spans 3.6 kb and consists of four exons and three introns. Cross-species Northern analysis reveals a mouse homolog of a similar size and with an expression profile similar to those of the human gene. We have named this gene ZNRD1 for zinc ribbon domain-containing 1 protein.</AbstractText>
        <CopyrightInformation>Copyright 2000 Academic Press.</CopyrightInformation>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Fan</LastName>
          <ForeName>W</ForeName>
          <Initials>W</Initials>
          <AffiliationInfo>
            <Affiliation>Gene Logic Inc., 708 Quince Orchard Road, Gaithersburg, Maryland 20878, USA. wfan@genelogic.com</Affiliation>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Wang</LastName>
          <ForeName>Z</ForeName>
          <Initials>Z</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Kyzysztof</LastName>
          <ForeName>F</ForeName>
          <Initials>F</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Prange</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Lennon</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <DataBankList CompleteYN="Y">
        <DataBank>
          <DataBankName>GENBANK</DataBankName>
          <AccessionNumberList>
            <AccessionNumber>AF024617</AccessionNumber>
            <AccessionNumber>L27650</AccessionNumber>
            <AccessionNumber>P32529</AccessionNumber>
            <AccessionNumber>X70805</AccessionNumber>
          </AccessionNumberList>
        </DataBank>
      </DataBankList>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>United States</Country>
      <MedlineTA>Genomics</MedlineTA>
      <NlmUniqueID>8800135</NlmUniqueID>
      <ISSNLinking>0888-7543</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="C406241">POLR1H protein, human</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
        <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D005805" MajorTopicYN="Y">Genes, MHC Class I</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName>
      </MeshHeading>
    </MeshHeadingList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2000</Year>
        <Month>2</Month>
        <Day>9</Day>
        <Hour>9</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2000</Year>
        <Month>4</Month>
        <Day>15</Day>
        <Hour>9</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>2000</Year>
        <Month>2</Month>
        <Day>9</Day>
        <Hour>9</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">10662553</ArticleId>
      <ArticleId IdType="doi">10.1006/geno.1999.6040</ArticleId>
      <ArticleId IdType="pii">S0888-7543(99)96040-8</ArticleId>
    </ArticleIdList>
  </PubmedData>
</PubmedArticle>















<!--  GeneralNote -->
<PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">1697029</PMID>
    <DateCompleted>
      <Year>1990</Year>
      <Month>09</Month>
      <Day>25</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>09</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Print">0025-729X</ISSN>
        <JournalIssue CitedMedium="Print">
          <Volume>153</Volume>
          <Issue>4</Issue>
          <PubDate>
            <Year>1990</Year>
            <Month>Aug</Month>
            <Day>20</Day>
          </PubDate>
        </JournalIssue>
        <Title>The Medical journal of Australia</Title>
        <ISOAbbreviation>Med J Aust</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Not-for-resuscitation orders in cancer patients--principles of decision-making.</ArticleTitle>
      <Pagination>
        <MedlinePgn>225-9</MedlinePgn>
      </Pagination>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Haines</LastName>
          <ForeName>I E</ForeName>
          <Initials>IE</Initials>
          <AffiliationInfo>
            <Affiliation>Repatriation General Hospital, Heidelberg, VIC.</Affiliation>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Zalcberg</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Buchanan</LastName>
          <ForeName>J D</ForeName>
          <Initials>JD</Initials>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <PublicationTypeList>
        <PublicationType UI="D002363">Case Reports</PublicationType>
        <PublicationType UI="D016428">Journal Article</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>Australia</Country>
      <MedlineTA>Med J Aust</MedlineTA>
      <NlmUniqueID>0400714</NlmUniqueID>
      <ISSNLinking>0025-729X</ISSNLinking>
    </MedlineJournalInfo>
    <CitationSubset>E</CitationSubset>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004992" MajorTopicYN="N">Ethics, Medical</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D005066" MajorTopicYN="Y">Euthanasia, Passive</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
        <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010358" MajorTopicYN="N">Patient Participation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010817" MajorTopicYN="N">Physician-Patient Relations</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D012151" MajorTopicYN="Y">Resuscitation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D012944" MajorTopicYN="N">Social Support</DescriptorName>
      </MeshHeading>
    </MeshHeadingList>
    <OtherID Source="KIE">123337</OtherID>
    <OtherID Source="NRCBL">VF 20.5.1</OtherID>
    <KeywordList Owner="KIE">
      <Keyword MajorTopicYN="N">Death and Euthanasia</Keyword>
    </KeywordList>
    <GeneralNote Owner="KIE">12 refs.</GeneralNote>
    <GeneralNote Owner="KIE">KIE Bib: resuscitation orders</GeneralNote>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="pubmed">
        <Year>1990</Year>
        <Month>8</Month>
        <Day>20</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>1990</Year>
        <Month>8</Month>
        <Day>20</Day>
        <Hour>0</Hour>
        <Minute>1</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>1990</Year>
        <Month>8</Month>
        <Day>20</Day>
        <Hour>0</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">1697029</ArticleId>
      <ArticleId IdType="doi">10.5694/j.1326-5377.1990.tb136867.x</ArticleId>
    </ArticleIdList>
  </PubmedData>
</PubmedArticle>



<!--  AuthorList complete -->
<PubmedArticle>
  <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
    <PMID Version="1">31897414</PMID>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>12</Day>
    </DateRevised>
    <Article PubModel="Print-Electronic">
      <Journal>
        <ISSN IssnType="Print">2347-3584</ISSN>
        <JournalIssue CitedMedium="Print">
          <Volume>30</Volume>
          <Issue>4</Issue>
          <PubDate>
            <Year>2019</Year>
            <Month>Dec</Month>
          </PubDate>
        </JournalIssue>
        <Title>Virusdisease</Title>
        <ISOAbbreviation>Virusdisease</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India.</ArticleTitle>
      <Pagination>
        <MedlinePgn>490-497</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13337-019-00553-2</ELocationID>
      <Abstract>
        <AbstractText>The availability of generic direct acting antivirals (DAAs) for hepatitis C virus (HCV) treatment has prompted many low-and-middle-income countries to launch HCV elimination programs. Because the efficacy of some of these generic DAAs varies by HCV viral subtype, information on subtype distribution can contribute important information to these elimination programs. We conducted a cross-sectional serosurvey to characterize HCV subtype diversity among HIV positive people who inject drugs (PWID) across 14 cities in India. Of 801 HIV positive PWID sampled, 639 tested HCV antibody positive (78.9%). Among 105 samples sequenced, genotype 3 (58.1%) was the most commonly observed followed by genotype 1 (36.2%) and genotype 6 (5.7%). Of the genotype 3 infections, 65% were subtype 3a and 35% were subtype 3b. Of the genotype 1 infections, 94% were subtype 1a and 6% were subtype 1b. All genotype 6 samples were subtype 6n. There was some variability in genotype diversity depending on geographic region and PWID epidemic stage with greater diversity observed in older PWID epidemics. One sequence, HY018, did not cluster with any known reference sequences in phylogenetic analysis. Nearly 80% of HIV infected PWID across India are co-infected with HCV, and subtype prevalence and genetic diversity varied by region and PWID epidemic stage. HCV elimination programs in India will need to consider HCV subtype.</AbstractText>
        <CopyrightInformation>© Indian Virological Society 2019.</CopyrightInformation>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Solomon</LastName>
          <ForeName>S S</ForeName>
          <Initials>SS</Initials>
          <AffiliationInfo>
            <Affiliation>1Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD USA.</Affiliation>
            <Identifier Source="GRID">grid.21107.35</Identifier>
            <Identifier Source="ISNI">0000 0001 2171 9311</Identifier>
          </AffiliationInfo>
          <AffiliationInfo>
            <Affiliation>2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA.</Affiliation>
            <Identifier Source="GRID">grid.21107.35</Identifier>
            <Identifier Source="ISNI">0000 0001 2171 9311</Identifier>
          </AffiliationInfo>
          <AffiliationInfo>
            <Affiliation>3YR Gaitonde Centre for AIDS Research and Education, Chennai, India.</Affiliation>
            <Identifier Source="GRID">grid.433847.f</Identifier>
            <Identifier Source="ISNI">0000 0000 9555 1294</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Boon</LastName>
          <ForeName>D</ForeName>
          <Initials>D</Initials>
          <AffiliationInfo>
            <Affiliation>2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA.</Affiliation>
            <Identifier Source="GRID">grid.21107.35</Identifier>
            <Identifier Source="ISNI">0000 0001 2171 9311</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Saravanan</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
          <AffiliationInfo>
            <Affiliation>3YR Gaitonde Centre for AIDS Research and Education, Chennai, India.</Affiliation>
            <Identifier Source="GRID">grid.433847.f</Identifier>
            <Identifier Source="ISNI">0000 0000 9555 1294</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Srikrishnan</LastName>
          <ForeName>A K</ForeName>
          <Initials>AK</Initials>
          <AffiliationInfo>
            <Affiliation>3YR Gaitonde Centre for AIDS Research and Education, Chennai, India.</Affiliation>
            <Identifier Source="GRID">grid.433847.f</Identifier>
            <Identifier Source="ISNI">0000 0000 9555 1294</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Vasudevan</LastName>
          <ForeName>C K</ForeName>
          <Initials>CK</Initials>
          <AffiliationInfo>
            <Affiliation>3YR Gaitonde Centre for AIDS Research and Education, Chennai, India.</Affiliation>
            <Identifier Source="GRID">grid.433847.f</Identifier>
            <Identifier Source="ISNI">0000 0000 9555 1294</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Balakrishnan</LastName>
          <ForeName>P</ForeName>
          <Initials>P</Initials>
          <AffiliationInfo>
            <Affiliation>3YR Gaitonde Centre for AIDS Research and Education, Chennai, India.</Affiliation>
            <Identifier Source="GRID">grid.433847.f</Identifier>
            <Identifier Source="ISNI">0000 0000 9555 1294</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Persaud</LastName>
          <ForeName>D</ForeName>
          <Initials>D</Initials>
          <AffiliationInfo>
            <Affiliation>4Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD USA.</Affiliation>
            <Identifier Source="GRID">grid.21107.35</Identifier>
            <Identifier Source="ISNI">0000 0001 2171 9311</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Ray</LastName>
          <ForeName>S C</ForeName>
          <Initials>SC</Initials>
          <AffiliationInfo>
            <Affiliation>1Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD USA.</Affiliation>
            <Identifier Source="GRID">grid.21107.35</Identifier>
            <Identifier Source="ISNI">0000 0001 2171 9311</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Mehta</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
          <Identifier Source="ORCID">0000-0002-2523-0959</Identifier>
          <AffiliationInfo>
            <Affiliation>5Department of Medicine, University of California at San Diego School of Medicine, La Jolla, CA USA.</Affiliation>
            <Identifier Source="GRID">grid.266100.3</Identifier>
            <Identifier Source="ISNI">0000 0001 2107 4242</Identifier>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Mehta</LastName>
          <ForeName>S H</ForeName>
          <Initials>SH</Initials>
          <AffiliationInfo>
            <Affiliation>2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA.</Affiliation>
            <Identifier Source="GRID">grid.21107.35</Identifier>
            <Identifier Source="ISNI">0000 0001 2171 9311</Identifier>
          </AffiliationInfo>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <GrantList CompleteYN="Y">
        <Grant>
          <GrantID>T32 DA007292</GrantID>
          <Acronym>DA</Acronym>
          <Agency>NIDA NIH HHS</Agency>
          <Country>United States</Country>
        </Grant>
        <Grant>
          <GrantID>R01 DA026727</GrantID>
          <Acronym>DA</Acronym>
          <Agency>NIDA NIH HHS</Agency>
          <Country>United States</Country>
        </Grant>
        <Grant>
          <GrantID>R56 DA012568</GrantID>
          <Acronym>DA</Acronym>
          <Agency>NIDA NIH HHS</Agency>
          <Country>United States</Country>
        </Grant>
        <Grant>
          <GrantID>P30 AI036214</GrantID>
          <Acronym>AI</Acronym>
          <Agency>NIAID NIH HHS</Agency>
          <Country>United States</Country>
        </Grant>
        <Grant>
          <GrantID>R01 DA012568</GrantID>
          <Acronym>DA</Acronym>
          <Agency>NIDA NIH HHS</Agency>
          <Country>United States</Country>
        </Grant>
      </GrantList>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
      </PublicationTypeList>
      <ArticleDate DateType="Electronic">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>07</Day>
      </ArticleDate>
    </Article>
    <MedlineJournalInfo>
      <Country>India</Country>
      <MedlineTA>Virusdisease</MedlineTA>
      <NlmUniqueID>101624144</NlmUniqueID>
      <ISSNLinking>2347-3584</ISSNLinking>
    </MedlineJournalInfo>
    <KeywordList Owner="NOTNLM">
      <Keyword MajorTopicYN="N">Genotype</Keyword>
      <Keyword MajorTopicYN="N">Hepatitis C virus</Keyword>
      <Keyword MajorTopicYN="N">India</Keyword>
      <Keyword MajorTopicYN="N">Low-and-middle-income country</Keyword>
      <Keyword MajorTopicYN="N">People who inject drugs</Keyword>
    </KeywordList>
    <CoiStatement>Conflict of interestThe authors have no conflicts of interest.</CoiStatement>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="received">
        <Year>2019</Year>
        <Month>06</Month>
        <Day>19</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>11</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>4</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>4</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>4</Day>
        <Hour>6</Hour>
        <Minute>1</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">31897414</ArticleId>
      <ArticleId IdType="doi">10.1007/s13337-019-00553-2</ArticleId>
      <ArticleId IdType="pii">553</ArticleId>
      <ArticleId IdType="pmc">PMC6917681</ArticleId>
    </ArticleIdList>
    <ReferenceList>
      <Reference>
        <Citation>Drugs. 2017 Mar;77(3):313-318</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">28078644</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">28404132</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Clin Infect Dis. 2016 May 15;62(10):1287-1288</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">26936668</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Diagn Microbiol Infect Dis. 2008 Aug;61(4):408-14</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">18455899</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Lancet Infect Dis. 2015 Jan;15(1):36-45</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">25486851</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Indian J Gastroenterol. 2016 Nov;35(6):469-477</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">27844277</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Sex Transm Infect. 2006 Jun;82 Suppl 3:iii10-17</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">16735287</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Microbiol. 2003 Nov;41(11):5240-4</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">14605173</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Gastroenterology. 2017 Jul;153(1):113-122</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">28390869</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Lancet HIV. 2016 Aug;3(8):e361-e387</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">27470028</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Hepatol Res. 2007 May;37(5):337-45</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">17441806</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>N Engl J Med. 2015 Dec 31;373(27):2599-607</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">26571066</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Nat Methods. 2012 Jul 30;9(8):772</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">22847109</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Liver Int. 2011 Jul;31 Suppl 2:61-80</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">21651703</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Lancet Infect Dis. 2016 Jul;16(7):797-808</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">26922272</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Arch Virol. 2012 Nov;157(11):2083-93</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">22791109</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Indian J Med Res. 2011 Mar;133:326-31</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">21441689</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Mol Biol Evol. 2013 Dec;30(12):2725-9</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">24132122</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Syst Biol. 2003 Oct;52(5):696-704</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">14530136</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Infect Dis. 2000 Sep;182(3):698-707</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">10950762</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>J Clin Exp Hepatol. 2018 Mar;8(1):7-14</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">29743791</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Infect Genet Evol. 2014 Jun;24:57-67</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">24650917</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Lancet Glob Health. 2017 Dec;5(12):e1192-e1207</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">29074409</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>Indian J Med Microbiol. 2013 Oct-Dec;31(4):349-53</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">24064640</ArticleId>
        </ArticleIdList>
      </Reference>
      <Reference>
        <Citation>PLoS One. 2015 May 11;10(5):e0126764</Citation>
        <ArticleIdList>
          <ArticleId IdType="pubmed">25962112</ArticleId>
        </ArticleIdList>
      </Reference>
    </ReferenceList>
  </PubmedData>
</PubmedArticle>



















<!--  GeneSymbolList -->


<PubmedArticle>
  <MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">8159434</PMID>
    <DateCompleted>
      <Year>1994</Year>
      <Month>05</Month>
      <Day>19</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>12</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Print">0304-3959</ISSN>
        <JournalIssue CitedMedium="Print">
          <Volume>56</Volume>
          <Issue>1</Issue>
          <PubDate>
            <Year>1994</Year>
            <Month>Jan</Month>
          </PubDate>
        </JournalIssue>
        <Title>Pain</Title>
        <ISOAbbreviation>Pain</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons.</ArticleTitle>
      <Pagination>
        <MedlinePgn>103-112</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1016/0304-3959(94)90155-4</ELocationID>
      <Abstract>
        <AbstractText>Expression of the immediate-early genes (IEG) c-FOS, NGF1-A and c-JUN was induced by noxious thermal stimulation in neurons of the rat spinal cord dorsal horn. Intravenous injection of Kelatorphan (5, 10 and 20 mg/kg), an inhibitor of multiple enkephalin-degrading enzymes, 20 min before noxious stimulation reduced the overall number of dorsal horn neurons expressing c-FOS and NGF1-A by up to 20-30%. While c-FOS expression was suppressed in superficial and deep laminae of the spinal cord, NGF1-A and c-JUN was only suppressed in superficial laminae. Morphine (5, 7.5 and 10 mg/kg) produced a dose-dependent reduction of c-FOS expression by up to 70% only when injected before noxious stimulation. Morphine injected 10 min after the noxious treatment was virtually ineffective. The depressant effect of Kelatorphan and morphine could be prevented by prior application of the opioid antagonist naloxone. Naloxone itself slightly increased the overall number of c-FOS-positive neurons in all laminae of the spinal cord. The present data support the existence of a tonic release of endogenous opioid peptides at the spinal level and show that inhibition of their peptidase-induced degradation modulates IEG expression in dorsal horn neurons of the rat. The finding that opioid agonists were ineffective when applied after stimulation underline the necessity of pre-emptive analgesia to prevent long-term activity-dependent changes in spinal cord neurons.</AbstractText>
      </Abstract>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Tölle</LastName>
          <ForeName>Thomas R</ForeName>
          <Initials>TR</Initials>
          <AffiliationInfo>
            <Affiliation>Clinical Neurophannacology, Max-Planck-Institute of Psychiatry, Clinical Institute, 80804 München 40 Germany Institute of Histology and Embryology, Faculty of Medicine of Oporto, 4200 Porto Portugal Imperial Cancer Research Fund. Biochemistry of the Cell Nucleus Laboratory, London UK Université René Descartes, Unité de Pharmacochimie Moléculaire, ParisFrance.</Affiliation>
          </AffiliationInfo>
        </Author>
        <Author ValidYN="Y">
          <LastName>Schadrack</LastName>
          <ForeName>Jan</ForeName>
          <Initials>J</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Castro-Lopes</LastName>
          <ForeName>Jose M</ForeName>
          <Initials>JM</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Evan</LastName>
          <ForeName>Gerard</ForeName>
          <Initials>G</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Roques</LastName>
          <ForeName>Bernard P</ForeName>
          <Initials>BP</Initials>
        </Author>
        <Author ValidYN="Y">
          <LastName>Zieglgänsberger</LastName>
          <ForeName>Walter</ForeName>
          <Initials>W</Initials>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>United States</Country>
      <MedlineTA>Pain</MedlineTA>
      <NlmUniqueID>7508686</NlmUniqueID>
      <ISSNLinking>0304-3959</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D000700">Analgesics</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>36B82AMQ7N</RegistryNumber>
        <NameOfSubstance UI="D009270">Naloxone</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>46BBW2U5D6</RegistryNumber>
        <NameOfSubstance UI="C042591">kelatorphan</NameOfSubstance>
      </Chemical>
      <Chemical>
        <RegistryNumber>76I7G6D29C</RegistryNumber>
        <NameOfSubstance UI="D009020">Morphine</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <GeneSymbolList>
      <GeneSymbol>NGF1-A</GeneSymbol>
      <GeneSymbol>c-fos</GeneSymbol>
      <GeneSymbol>c-jun</GeneSymbol>
    </GeneSymbolList>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName>
        <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName>
        <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
        <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D017781" MajorTopicYN="N">Genes, Immediate-Early</DescriptorName>
        <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006358" MajorTopicYN="N">Hot Temperature</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName>
        <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009270" MajorTopicYN="N">Naloxone</DescriptorName>
        <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
        <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
        <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D010812" MajorTopicYN="N">Physical Stimulation</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName>
        <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
        <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
      </MeshHeading>
    </MeshHeadingList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="pubmed">
        <Year>1994</Year>
        <Month>1</Month>
        <Day>1</Day>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>1994</Year>
        <Month>1</Month>
        <Day>1</Day>
        <Hour>0</Hour>
        <Minute>1</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>1994</Year>
        <Month>1</Month>
        <Day>1</Day>
        <Hour>0</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">8159434</ArticleId>
      <ArticleId IdType="pii">00006396-199401000-00013</ArticleId>
      <ArticleId IdType="doi">10.1016/0304-3959(94)90155-4</ArticleId>
    </ArticleIdList>
  </PubmedData>
</PubmedArticle>














<!-- Recursive ReferenceList -->

<PubmedArticle>
  <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
    <PMID Version="1">31932710</PMID>
    <DateCompleted>
      <Year>2020</Year>
      <Month>04</Month>
      <Day>27</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>12</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Electronic">1471-0080</ISSN>
        <JournalIssue CitedMedium="Internet">
          <Volume>21</Volume>
          <Issue>3</Issue>
          <PubDate>
            <Year>2020</Year>
            <Month>03</Month>
          </PubDate>
        </JournalIssue>
        <Title>Nature reviews. Molecular cell biology</Title>
        <ISOAbbreviation>Nat Rev Mol Cell Biol</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Collagen around the clock.</ArticleTitle>
      <Pagination>
        <MedlinePgn>120-121</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41580-020-0211-6</ELocationID>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Strzyz</LastName>
          <ForeName>Paulina</ForeName>
          <Initials>P</Initials>
          <AffiliationInfo>
            <Affiliation>Nature Reviews Molecular Cell Biology, . nrm@nature.com.</Affiliation>
          </AffiliationInfo>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
        <PublicationType UI="D016420">Comment</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>England</Country>
      <MedlineTA>Nat Rev Mol Cell Biol</MedlineTA>
      <NlmUniqueID>100962782</NlmUniqueID>
      <ISSNLinking>1471-0072</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>9007-34-5</RegistryNumber>
        <NameOfSubstance UI="D003094">Collagen</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <CommentsCorrectionsList>
      <CommentsCorrections RefType="CommentOn">
        <RefSource>Nat Cell Biol. 2020 Jan;22(1):74-86</RefSource>
        <PMID Version="1">31907414</PMID>
      </CommentsCorrections>
    </CommentsCorrectionsList>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D003094" MajorTopicYN="Y">Collagen</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D055571" MajorTopicYN="Y">Secretory Pathway</DescriptorName>
      </MeshHeading>
    </MeshHeadingList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>15</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2020</Year>
        <Month>4</Month>
        <Day>28</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>15</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">31932710</ArticleId>
      <ArticleId IdType="doi">10.1038/s41580-020-0211-6</ArticleId>
      <ArticleId IdType="pii">10.1038/s41580-020-0211-6</ArticleId>
    </ArticleIdList>
    <ReferenceList>
      <ReferenceList>
        <Title>Original article</Title>
        <Reference>
          <Citation>Chang, J. et al. Circadian control of the secretory pathway maintains collagen homeostasis. Nat. Cell Biol. 22, 74–86 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41556-019-0441-z</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
      <ReferenceList>
        <Title>Related article</Title>
        <Reference>
          <Citation>Patke, A., Young, M. W. &amp; Axelrod, S. Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/s41580-019-0179-2 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-019-0179-2</ArticleId>
            <ArticleId IdType="pubmed">31768006</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </ReferenceList>
  </PubmedData>
</PubmedArticle>
<PubmedArticle>
  <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
    <PMID Version="1">31942066</PMID>
    <DateCompleted>
      <Year>2020</Year>
      <Month>04</Month>
      <Day>27</Day>
    </DateCompleted>
    <DateRevised>
      <Year>2021</Year>
      <Month>01</Month>
      <Day>12</Day>
    </DateRevised>
    <Article PubModel="Print">
      <Journal>
        <ISSN IssnType="Electronic">1471-0080</ISSN>
        <JournalIssue CitedMedium="Internet">
          <Volume>21</Volume>
          <Issue>3</Issue>
          <PubDate>
            <Year>2020</Year>
            <Month>03</Month>
          </PubDate>
        </JournalIssue>
        <Title>Nature reviews. Molecular cell biology</Title>
        <ISOAbbreviation>Nat Rev Mol Cell Biol</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Lipid transfer at ER-isolation membrane contacts.</ArticleTitle>
      <Pagination>
        <MedlinePgn>121</MedlinePgn>
      </Pagination>
      <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41580-020-0212-5</ELocationID>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Zhang</LastName>
          <ForeName>Hong</ForeName>
          <Initials>H</Initials>
          <AffiliationInfo>
            <Affiliation>Institute of Biophysics, Chinese Academy of Sciences, Beijing, P. R. China. hongzhang@ibp.ac.cn.</Affiliation>
          </AffiliationInfo>
        </Author>
      </AuthorList>
      <Language>eng</Language>
      <PublicationTypeList>
        <PublicationType UI="D016428">Journal Article</PublicationType>
        <PublicationType UI="D016420">Comment</PublicationType>
      </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
      <Country>England</Country>
      <MedlineTA>Nat Rev Mol Cell Biol</MedlineTA>
      <NlmUniqueID>100962782</NlmUniqueID>
      <ISSNLinking>1471-0072</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
      <Chemical>
        <RegistryNumber>0</RegistryNumber>
        <NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
      </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <CommentsCorrectionsList>
      <CommentsCorrections RefType="CommentOn">
        <RefSource>Nat Rev Mol Cell Biol. 2019 Feb;20(2):85-101</RefSource>
        <PMID Version="1">30337668</PMID>
      </CommentsCorrections>
    </CommentsCorrectionsList>
    <MeshHeadingList>
      <MeshHeading>
        <DescriptorName UI="D004721" MajorTopicYN="Y">Endoplasmic Reticulum</DescriptorName>
      </MeshHeading>
      <MeshHeading>
        <DescriptorName UI="D008055" MajorTopicYN="Y">Lipids</DescriptorName>
      </MeshHeading>
    </MeshHeadingList>
  </MedlineCitation>
  <PubmedData>
    <History>
      <PubMedPubDate PubStatus="pubmed">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>17</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="medline">
        <Year>2020</Year>
        <Month>4</Month>
        <Day>28</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
      <PubMedPubDate PubStatus="entrez">
        <Year>2020</Year>
        <Month>1</Month>
        <Day>17</Day>
        <Hour>6</Hour>
        <Minute>0</Minute>
      </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
      <ArticleId IdType="pubmed">31942066</ArticleId>
      <ArticleId IdType="doi">10.1038/s41580-020-0212-5</ArticleId>
      <ArticleId IdType="pii">10.1038/s41580-020-0212-5</ArticleId>
    </ArticleIdList>
    <ReferenceList>
      <ReferenceList>
        <Title>Original articles</Title>
        <Reference>
          <Citation>Maeda, S. et al. The autophagic membrane tether ATG2A transfers lipids between membranes. eLife 8, e45777 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.45777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osawa, T. et al. Atg2 mediates direct lipid transfer between membranes for autophagosome formation. Nat. Struct. Mol. Biol. 26, 281–288 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41594-019-0203-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valverde, D. P. et al. ATG2 transports lipids to promote autophagosome biogenesis. J. Cell Biol. 218, 1787–1798 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201811139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao, Y. G. et al. The ER-localized transmembrane protein EPG-3/VMP1 regulates SERCA activity to control ER-isolation membrane contacts for autophagosome formation. Mol. Cell 67, 974–989 (2017)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2017.08.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao, Y. G. et al. The ER contact proteins VAPA/B interact with multiple autophagy proteins to modulate autophagosome biogenesis. Curr. Biol. 28, 1234–1245 (2018)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cub.2018.03.002</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
      <ReferenceList>
        <Title>Related article</Title>
        <Reference>
          <Citation>Wong, L. H. et al. Lipid transfer proteins: the lipid commute via shuttles, bridges and tubes. Nat. Rev. Mol. Cell Biol. 20, 85–101 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-018-0071-5</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </ReferenceList>
  </PubmedData>
</PubmedArticle>








<!-- CREATED -->
<!--  False SpaceFlightMission -->
<!--  False ObjectList -->

   <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
       <SpaceFlightMission>False Mission</SpaceFlightMission>
      <PMID Version="1">111111</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1097-6760</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>77</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of emergency medicine</Title>
          <ISOAbbreviation>Ann Emerg Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1-e57</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">S0196-0644(20)31355-X</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.annemergmed.2020.10.024</ELocationID>
        <Abstract>
          <AbstractText>This clinical policy from the American College of Emergency Physicians is a revision of the 2009 "Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia." A writing subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer the following clinical questions: (1) In the adult emergency department patient diagnosed with community-acquired pneumonia, what clinical decision aids can inform the determination of patient disposition? (2) In the adult emergency department patient with community-acquired pneumonia, what biomarkers can be used to direct initial antimicrobial therapy? (3) In the adult emergency department patient diagnosed with community-acquired pneumonia, does a single dose of parenteral antibiotics in the emergency department followed by oral treatment versus oral treatment alone improve outcomes? Evidence was graded and recommendations were made based on the strength of the available data.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <CollectiveName>American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Community-Acquired Pneumonia</CollectiveName>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Michael D</ForeName>
            <Initials>MD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fee</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mace</LastName>
            <ForeName>Sharon E</ForeName>
            <Initials>SE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maughan</LastName>
            <ForeName>Brandon</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perkins</LastName>
            <ForeName>John C</ForeName>
            <Initials>JC</Initials>
            <Suffix>Jr</Suffix>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaji</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wolf</LastName>
            <ForeName>Stephen J</ForeName>
            <Initials>SJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ann Emerg Med</MedlineTA>
        <NlmUniqueID>8002646</NlmUniqueID>
        <ISSNLinking>0196-0644</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Wolf</LastName>
          <ForeName>Stephen J</ForeName>
          <Initials>SJ</Initials>
          <Suffix>Jr</Suffix>
          <Identifier Source="ORCID">0000-0000-0000-0000</Identifier>
          <AffiliationInfo>
              <Affiliation>Department of false</Affiliation>
               <Identifier Source="GRID">grid.21122.35</Identifier>
            </AffiliationInfo>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Byyny</LastName>
          <ForeName>Richard</ForeName>
          <Initials>R</Initials>
          <Suffix>Jr2</Suffix>
          <Identifier Source="ORCID">0000-0000-0000-0002</Identifier>
          <AffiliationInfo>
              <Affiliation>Department of false</Affiliation>
              <Identifier Source="GRID">grid.21122.35</Identifier>
            </AffiliationInfo>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349374</ArticleId>
        <ArticleId IdType="pii">S0196-0644(20)31355-X</ArticleId>
        <ArticleId IdType="doi">10.1016/j.annemergmed.2020.10.024</ArticleId>
      </ArticleIdList>
      <ObjectList>
        <Object CDATA="pet" >
            <Param CDATA="AAAA" >hamster</Param>
            <Param CDATA="BBBB" >dog</Param>
        </Object>
         <Object CDATA="pet2" >
            <Param CDATA="AAAA" >cat</Param>
        </Object>
      </ObjectList>
    </PubmedData>
  </PubmedArticle>






  <PubmedBookArticle>
    <BookDocument>
      <PMID Version="1">92349121</PMID>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33349374</ArticleId>
        <ArticleId IdType="pii">S0196-0644(20)31355-X</ArticleId>
        <ArticleId IdType="doi">10.1016/j.annemergmed.2020.10.024</ArticleId>
      </ArticleIdList>
      <Book>
        <Publisher>
          <PublisherName>PublisherName</PublisherName>
          <PublisherLocation>Location</PublisherLocation>
        </Publisher>
        <BookTitle> Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia. </BookTitle>
        <PubDate>
          <Year>2021</Year>
          <Month>Jan</Month>
        </PubDate>
        <BeginningDate>
          <Year>2020</Year>
          <Month>Jan</Month>
        </BeginningDate>
        <EndingDate>
          <Year>2020</Year>
          <Month>Jan</Month>
        </EndingDate>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <CollectiveName>American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Community-Acquired Pneumonia</CollectiveName>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Michael D</ForeName>
            <Initials>MD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fee</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
          </Author>
        </AuthorList>
        <InvestigatorList>
          <Investigator ValidYN="Y">
            <LastName>Wolf</LastName>
            <ForeName>Stephen J</ForeName>
            <Initials>SJ</Initials>
          </Investigator>
          <Investigator ValidYN="Y">
            <LastName>Byyny</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
          </Investigator>
        </InvestigatorList>
        <Volume>145</Volume>
        <VolumeTitle>Book</VolumeTitle>
        <Edition>123</Edition>
        <CollectionTitle>Book of books</CollectionTitle>
        <Isbn>123-456</Isbn>
        <Isbn>456-789</Isbn>
        <ELocationID EIdType="pii" ValidYN="Y">S1878-8750(20)32273-7</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2020.10.081</ELocationID>
        <Medium>hello</Medium>
        <ReportNumber>66</ReportNumber>
      </Book>
      <LocationLabel Type="section">sectionValue</LocationLabel>
      <LocationLabel Type="chapter">chapterValue</LocationLabel>
      <VernacularTitle >VernacularTitleValue</VernacularTitle>
      <Pagination>
        <StartPage>2 </StartPage>
        <EndPage>5</EndPage>
        <MedlinePgn> 12-A </MedlinePgn>
      </Pagination>
      <Language >eng</Language>
      <Language >ita</Language>
      <AuthorList CompleteYN="Y">
        <Author ValidYN="Y">
          <LastName>Lu</LastName>
          <ForeName>Guangyu</ForeName>
          <Initials>G</Initials>
          <AffiliationInfo>
            <Affiliation>Department of Preventive Medicine, Medical College of Yangzhou University, Yangzhou University, Yangzhou, China.</Affiliation>
          </AffiliationInfo>
        </Author>
      </AuthorList>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Wolf</LastName>
          <ForeName>Stephen J</ForeName>
          <Initials>SJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>ByynyAAA</LastName>
          <ForeName>Richard</ForeName>
          <Initials>R</Initials>
        </Investigator>
      </InvestigatorList>
      <PublicationType UI="D016428">Journal Article</PublicationType>
      <Abstract>
        <AbstractText>Changes in DNA methylation, whether hypo- or hypermethylation, have been shown to be associated with the progression of colorectal cancer. Methylation changes substantially in the progression from normal mucosa to adenoma and to carcinoma. .</AbstractText>
        <CopyrightInformation>Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation>
      </Abstract>
      <Sections>
        <Section>
          <LocationLabel Type="chapter">chapterValueSection</LocationLabel>
          <SectionTitle>TitleSection1</SectionTitle>
          <Section>
            <LocationLabel Type="chapte2r">subsection</LocationLabel>
            <SectionTitle>Titlesubsection</SectionTitle>
          </Section>
        </Section>
        <Section>
          <LocationLabel Type="chapter23">chapterValueSection2</LocationLabel>
          <SectionTitle>TitleSection2</SectionTitle>
        </Section>
      </Sections>
      <KeywordList Owner="NLM">
        <Keyword MajorTopicYN="Y">Keyword1</Keyword>
        <Keyword MajorTopicYN="N">Keyword2</Keyword>
      </KeywordList>
      <ContributionDate>
        <Year>2020</Year>
        <Month>Jan</Month>
      </ContributionDate>
      <DateRevised>
        <Year>2010</Year>
        <Month>Jan</Month>
      </DateRevised>
      <GrantList CompleteYN="Y">
        <Grant>
          <GrantID>090532</GrantID>
          <Agency>Wellcome Trust</Agency>
          <Country>United Kingdom</Country>
        </Grant>
        <Grant>
          <GrantID>090532/Z/09/Z</GrantID>
          <Agency>Wellcome Trust1</Agency>
          <Country>United Kingdom1</Country>
        </Grant>
      </GrantList>
      <ItemList CDATA="ItemAtt">
        <Item>Item1</Item>
        <Item>Item2</Item>
        <Item>Item3</Item>
      </ItemList>
      <ReferenceList>
        <Title>Reference</Title>
        <Reference>
          <Citation>Weldegiorgis M, Woodward M. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020;21:506 https://doi.org/10.1186/s12882-020-02151-7 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12882-020-02151-7</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </BookDocument>

    <PubmedBookData>
      <History>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
    </PubmedBookData>

    <ArticleIdList>
      <ArticleId IdType="pubmed">33348493</ArticleId>
      <ArticleId IdType="pii">S1878-8750(20)32273-7</ArticleId>
      <ArticleId IdType="doi">10.1016/j.wneu.2020.10.081</ArticleId>
    </ArticleIdList>
    <ObjectList>
      <Object CDATA="pet" >
        <Param CDATA="AAAA" >hamster</Param>
        <Param CDATA="BBBB" >dog</Param>
      </Object>
      <Object CDATA="pet2" >
        <Param CDATA="AAAA" >cat</Param>
      </Object>
    </ObjectList>
  </PubmedBookArticle>

  <DeleteCitation>
    <PMID Version="1">4955</PMID>
    <PMID Version="1">32421162</PMID>
    <PMID Version="1">32478799</PMID>
    <PMID Version="1">32848134</PMID>
    <PMID Version="1">33149272</PMID>
    <PMID Version="1">33320226</PMID>
    <PMID Version="1">33351031</PMID>
    <PMID Version="1">33351049</PMID>
    <PMID Version="1">33357395</PMID>
    <PMID Version="1">33394606</PMID>
    <PMID Version="1">33408380</PMID>
    <PMID Version="1">33412575</PMID>
    <PMID Version="1">33412576</PMID>
    <PMID Version="1">33412577</PMID>
    <PMID Version="1">33412578</PMID>
    <PMID Version="1">33412579</PMID>
    <PMID Version="1">33412580</PMID>
    <PMID Version="1">33412581</PMID>
    <PMID Version="1">33413955</PMID>
    <PMID Version="1">33416031</PMID>
    <PMID Version="1">33416058</PMID>
    <PMID Version="1">33416059</PMID>
    <PMID Version="1">33416060</PMID>
    <PMID Version="1">33416061</PMID>
    <PMID Version="1">33416445</PMID>
    <PMID Version="1">33416556</PMID>
    <PMID Version="1">33416587</PMID>
    <PMID Version="1">33416601</PMID>
    <PMID Version="1">33416637</PMID>
    <PMID Version="1">33416715</PMID>
    <PMID Version="1">33416716</PMID>
    <PMID Version="1">33416728</PMID>
    <PMID Version="1">33416759</PMID>
    <PMID Version="1">33416760</PMID>
    <PMID Version="1">33416812</PMID>
    <PMID Version="1">33416823</PMID>
    <PMID Version="1">33416824</PMID>
    <PMID Version="1">33416825</PMID>
    <PMID Version="1">33416827</PMID>
    <PMID Version="1">33417353</PMID>
    <PMID Version="1">33417493</PMID>
  </DeleteCitation>

</PubmedArticleSet>


